BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12559168)

  • 1. Initiation of angiogenic Kaposi's sarcoma lesions.
    Hayward GS
    Cancer Cell; 2003 Jan; 3(1):1-3. PubMed ID: 12559168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
    Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
    Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma. Coupling herpesvirus to angiogenesis.
    Boshoff C
    Nature; 1998 Jan; 391(6662):24-5. PubMed ID: 9422503
    [No Abstract]   [Full Text] [Related]  

  • 5. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.
    Abere B; Schulz TF
    Curr Opin Virol; 2016 Oct; 20():11-19. PubMed ID: 27518127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma and its associated herpesvirus.
    Mesri EA; Cesarman E; Boshoff C
    Nat Rev Cancer; 2010 Oct; 10(10):707-19. PubMed ID: 20865011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
    Sodhi A; Montaner S; Gutkind JS
    FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.
    Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA
    Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression.
    Bala K; Bosco R; Gramolelli S; Haas DA; Kati S; Pietrek M; Hävemeier A; Yakushko Y; Singh VV; Dittrich-Breiholz O; Kracht M; Schulz TF
    PLoS Pathog; 2012 Sep; 8(9):e1002927. PubMed ID: 23028325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.
    Montaner S; Sodhi A; Molinolo A; Bugge TH; Sawai ET; He Y; Li Y; Ray PE; Gutkind JS
    Cancer Cell; 2003 Jan; 3(1):23-36. PubMed ID: 12559173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
    Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
    PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
    Zhang X; Wang JF; Kunos G; Groopman JE
    Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
    Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
    Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma virally encoded, G-protein-coupled receptor: a paradigm for paracrine transformation.
    Martin D; Gutkind JS
    Methods Enzymol; 2009; 460():125-50. PubMed ID: 19446723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endolysosomal trafficking of viral G protein-coupled receptor functions in innate immunity and control of viral oncogenesis.
    Dong X; Cheng A; Zou Z; Yang YS; Sumpter RM; Huang CL; Bhagat G; Virgin HW; Lira SA; Levine B
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):2994-9. PubMed ID: 26929373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
    Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
    Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.
    Yang TY; Chen SC; Leach MW; Manfra D; Homey B; Wiekowski M; Sullivan L; Jenh CH; Narula SK; Chensue SW; Lira SA
    J Exp Med; 2000 Feb; 191(3):445-54. PubMed ID: 10662790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.